← Mechanisms of action
EBNA1
SINGLE PROTEINHuman herpesvirus 4 (strain B95-8)
Preferred name: Epstein-Barr nuclear antigen 1 ChEMBL ↗
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| recombinant epstein-barr virus vaccine | Immunity, active | experimental | Vaccine | EBNA1 immunity, active |
| cmd-003 | Immunity, passive | experimental | Cell therapy | Epstein-Barr T cells immunity, passive |
| ebna1-specific cytotoxic t-lymphocytes | Immunity, passive | experimental | Cell therapy | EBNA1 immunity, passive |
| mabel ctls | Immunity, passive | experimental | Cell therapy | EBNA1 immunity, passive |
| multivirus (cmv, ebv, adv)-specific t cells | Immunity, passive | experimental | Cell therapy | EBNA1 immunity, passive |
| vt-ebv-n | Immunity, passive | experimental | Cell therapy | EBNA1 immunity, passive |
| vk-2019 | Inhibitor | experimental | Small molecule | EBNA1 inhibitor |
| tabelecleucel | Other | experimental | Cell therapy | EBNA1 other |